Condition
Strength Outcomes
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed2
Enrolling By Invitation1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07523854Recruiting
Effect of Graft Type on Knee Muscle Strength After ACL Reconstruction
NCT07346703Not ApplicableEnrolling By Invitation
Effects of DHA in Patients With Multiple Sclerosis
NCT06690619Not ApplicableCompleted
Effects of Alpha-GPC on Muscle Power, GH Levels, and Cognitive Function
NCT04079010Not ApplicableCompleted
The Effect of Blood Flow Restriction With and Without Arginine on Physical Performance and Growth Hormone
Showing all 4 trials